Overview
Limbic is a UK-based AI mental health company that builds clinical-grade tools to support therapists and streamline access to psychological therapies. Their AI assessment and support product is integrated into NHS mental health services.
Limbic is a London-based neurotechnology company developing clinical-grade artificial intelligence tools designed to transform how mental health care is delivered and accessed. The company's flagship product is an AI-powered assessment and support platform that integrates directly into existing mental health service workflows, enabling faster, more accurate patient triage and intake. By combining advances in machine learning with evidence-based psychological frameworks, Limbic automates time-consuming administrative and clinical assessment processes that have traditionally burdened therapists. This allows clinicians to focus more of their time on direct patient care, improving both the quality and capacity of psychological therapy services.
Limbic has established a notable foothold within the UK's National Health Service, embedding its technology into NHS Talking Therapies services and reaching a significant portion of publicly funded mental health provision. The company has raised $12 million in Series A funding, signaling strong investor confidence in its clinical approach and commercial trajectory. Its integration within the NHS represents a meaningful regulatory and institutional validation, as NHS adoption demands rigorous clinical evidence and information governance standards. These milestones position Limbic as one of the most clinically credentialed AI mental health companies operating in the UK market today.
Limbic's work is significant to the broader neurotechnology industry because it demonstrates a viable pathway for deploying AI within highly regulated, publicly funded healthcare systems at scale. At a time when mental health services globally face unprecedented demand and workforce shortages, Limbic's model offers a scalable infrastructure solution rather than a consumer-facing workaround. The company's emphasis on clinical-grade standards raises the bar for what responsible AI deployment in mental health should look like, influencing industry norms around safety, evidence, and integration. As neurotech increasingly intersects with digital therapeutics and health system partnerships, Limbic serves as a compelling proof of concept for AI-augmented clinical care.
More in Mental Health Tech
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 ยท Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 ยท Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 ยท Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 ยท Industry
Company details
Category
๐ Mental Health Tech
Location
London, UK
Funding
Series A ยท $12M
Website
limbic.aiListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ